I primi 10 hansonwade.com competitors

beacon-intelligence.com

Explore the breakthrough mechanistic insights unveiled at SfN 2025, shaping the future of Alzheimer's Disease drug development.

proteindegradation.com

Aly Jackson is a Business Development Leader at Genentech/Roche. In this role, she leads diligence efforts and strategic deal discussions with potential partners to advance collaborations in drug…

autoimmunity.kenes.com

Got a question about Autoimmunity 2026? Ask us and come prepared to Prague, 14-17 May 2026 to explore together the complexity of autoimmune conditions.

beacontx.com

Explore groundbreaking results in laru-zova (AGTC-501) gene therapy for XLRP. Three-month data reveals significant retinal sensitivity improvement.

sutrobio.com

sutro biopharma, inc. is a public biotechnology company headquartered in south san francisco, california focused on clinical stage drug discovery, development and manufacturing company. using its integrated cell-free protein synthesis platform, xpresscf, to create a variety of protein therapeutics for cancer and autoimmune disorders. it focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (i/o) therapeutics, antibody-drug conjugates (adcs) and bispecific antibodies that are directed primarily against clinically validated targets. its product candidates include stro-001 and stro-002. stro-001 is an adc directed against the cancer target cd74, for patients with multiple myeloma and non-hodgkin lymphoma (nhl). stro-002 is an adc directed against folate receptor-alpha (folra), for patients with ovarian and endometrial cancers. stro-001 and stro-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its xpresscf platform.

antibodysociety.org

The remarkable increase in the number of antibody therapeutics in late-stage clinical studies that occurred between 2010 and 2022 has been documented in the ‘Antibodies to watch‘ article series, which […]

keystonesymposia.org

Keystone Symposia’s Health Equity Series seeks to raise awareness for health disparities in various disease states.

biopharma-asia.com

Single-pass tangential flow filtration (SPTFF) followed by multi-column chromatography (MCC) was used to continuously process a cell culture supernatant containing a monoclonal antibody (MAb) via Protein A affinity chromatography. This study demonstrates the benefit of such a combination in term of process robustness, productivity and economics of continuous processing. The SPTFF technique can readily be implemented for continuous processing via automated skids, and the flexibility of the technique allows for better control of the purification steps by normalizing the protein concentration from cell culture to chromatography. Moreover, while continuous multi-column operation results in high productivity at high protein titer, combining SPTFF and MCC when a low protein titer is used maintains this process

esmo.org

ESMO

ddw-online.com

The DDW Meet the Exhibitor Vodcast is a series of in-person interviews from key industry events. Here, Megan Thomas, Multimedia Editor at DDW, interviews Jay Gerlach, VP of Marketing at Sphere Fluidics, in the lead up to SLAS2025 in San Diego.